Labiotech.eu

News and Trends 30 Jun 2022

Evolved By Nature raises $120M for biotech silk technology

Evolved By Nature, the company creating a library of Activated Silk molecules from natural silk protein, has closed $120M in Series C financing. The round was led by Teachers’ Venture Growth (TVG), part of the C$242 billion Ontario Teachers’ Pension Plan Board, and Senator Investment Group, with participation from existing investors including Mousse Partners, Chanel, […]

June 30, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 30 Jun 2022

Funding doubled for company working on breakthrough auto-immune disease therapeutics

A Paris-based biotech company developing products for auto-immune diseases, announced today (June 30) that it has almost doubled its initial funding from two companies. The initial funding for Ermium Therapeutics of €6.3 million ($6.57 million) now stands at €12.3 million ($12.83 million) and has been supplied by Kurma Partners and Fountain Healthcare Partners. Ermium discovers […]

June 30, 2022 - 3 minutesmins - By Liza Laws

mereo biopharma brittle bone disease osteogenesis imperfecta

News and Trends 30 Jun 2022

Sirana Pharma and Pfizer to work on treatment for brittle bone disease

German biotech company Sirana Pharma GmbH has entered into a collaborative research agreement with Pfizer Inc. to investigate the potential identification and validation of a novel treatment concept for a rare bone disease, osteogenesis imperfecta (OI). Also called brittle bone disease, the condition is currently lacking approved drugs. Sirana Pharma focuses on the development of […]

June 30, 2022 - 2 minutesmins - By Jim Cornall

Inside Labiotech 30 Jun 2022

Meet Aurore and Liza, our new team members

Making conscious career decisions can be one of the biggest challenges we face, but having a clear aim and core values helps align our life paths to what matters the most to us. With a strong passion in SEO and growth hacking, our new Growth Marketing Manager Aurore was seeking new challenges to use her […]

June 30, 2022 - 8 minutesmins - By Yi-Jen Chang

decentralized trial virtual clinical trial

News and Trends 29 Jun 2022

Global call for scientists and inventors to form new startup

A fourth start-up but the first of its kind sees some high-profile companies join forces in a hunt for new global research talent. AION Labs, an Israel-based alliance of AstraZeneca, Merck, Pfizer, Teva, Israel Biotech Fund and Amazon Web Services (AWS) are focusing their start-up on the ‘prediction of clinical trial outcome in biomarker-stratified cancer patient […]

June 29, 2022 - 3 minutesmins - By Liza Laws

News and Trends 29 Jun 2022

Drug for childhood arthritis gets expanded approvals in the EU

A drug that can reduce the risk of flare and disease activity in children with enthesitis-related arthritis (ERA) and psoriatic arthritis (PsA) has been approved based on data from a clinical trial. The JUNIPERA trial, showing that Cosentyx (secukinumab) reduced the risk of flare and disease activity compared to placebo over two years in pediatric patients with […]

June 29, 2022 - 4 minutesmins - By Liza Laws

News and Trends 29 Jun 2022

ARCH Venture Partners launches $3B fund for biotech companies

ARCH Venture Partners has announced the closing of ARCH Venture Fund XII, with $2.975 billion to invest in the creation, development and funding of early stage biotechnology companies. The new fund follows the January 2021 announcement of the $1.941 billion ARCH Venture Fund XI. “All the fundamental innovations in biotechnology are accelerating, with huge promise […]

June 29, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 29 Jun 2022

Encouraging results from respiratory diseases vaccine trial

A biopharmaceutical company developing vaccines against infectious diseases has announced positive results for people with life threatening respiratory diseases. Icosavax says that in an interim phase 1/1b trial its vaccine IVX-121 has demonstrated robust immunological response to respiratory syncytial virus (RSV) in both young and older adult groups. The vaccine was generally tolerated with no […]

June 29, 2022 - 4 minutesmins - By Liza Laws

PBC clinical trials: Gannex doses first patient

News and Trends 29 Jun 2022

Deal to advance treatment for autoimmune disease worth $97M

MiroBio, which is developing checkpoint agonists to treat autoimmune disease, has announced the completion of a $97 million deal. The financing is being led by Medicxi with investments from OrbiMed and Monograph Capital and existing investors Oxford Science Enterprises, Samsara Biocapital, SR One and Advent Life Sciences. Funds will primarily be used to advance MiroBio’s […]

June 29, 2022 - 2 minutesmins - By Liza Laws

News and Trends 29 Jun 2022

Watch: Antibody Analytics opens new health sciences center

A new facility dedicated to the advancement of medical research and drug development opened its doors recently in Motherwell, Scotland, as part of a major expansion. Antibody Analytics, one of Scotland’s authorities on immunology, officially cut the ribbon on its new health sciences research center. The unveiling of the new Antibody Analytics Discovery Centre, funded […]

June 29, 2022 - 3 minutesmins - By Jim Cornall

Best in Biotech 29 Jun 2022

7 biotech books to dive into this summer

From the unprecedented speed at which the COVID-19 vaccines were developed to the biggest fraud case in biotech history, to a sci-fi story set in a post-apocalyptic city, here are seven biotech books to check out this summer. With record-breaking heat waves announcing the start of summer, there has never been a better time to […]

June 29, 2022 - 6 minutesmins - By Omnia Ibrahim

precision fermentation cheese croissant wine

In Depth 28 Jun 2022

Protecting our food supply chain with precision fermentation

Many nations are experiencing a food security crisis caused by geopolitical conflicts, extreme weather and supply chain disruption. A wave of precision fermentation companies is working to protect from future food price shocks by producing sustainable protein ingredients from microbes rather than traditional farms. The world is facing a protracted food security crisis with the […]

June 28, 2022 - 8 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Evolved By Nature raises $120M for biotech silk technology

Funding doubled for company working on breakthrough auto-immune disease therapeutics

Sirana Pharma and Pfizer to work on treatment for brittle bone disease

Meet Aurore and Liza, our new team members

Global call for scientists and inventors to form new startup

Drug for childhood arthritis gets expanded approvals in the EU

ARCH Venture Partners launches $3B fund for biotech companies

Encouraging results from respiratory diseases vaccine trial

Deal to advance treatment for autoimmune disease worth $97M

Watch: Antibody Analytics opens new health sciences center

7 biotech books to dive into this summer

Protecting our food supply chain with precision fermentation

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!